HENNA MUKHTAR MALIK M.D. NPI 1003099813

NPI Information

  • NPI: 1003099813
  • Provider Name: HENNA MUKHTAR MALIK, M.D.
  • Classification: Internal Medicine - 207RX0202X
  • Specialization: Medical Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 13215 DOTSON RD STE 300
    HOUSTON, TX
    ZIP 77070
  • Phone: (281) 894-8822

Map and Directions

Get Directions

NPI Details

Henna Mukhtar Malik, M.D. is a medical oncology internal medicine in Houston, TX with 22 years of experience. The provider is an internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer. Henna Mukhtar Malik, M.D. NPI is 1003099813. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

The provider's business location address is:

13215 DOTSON RD STE 300
HOUSTON, TX
ZIP 77070-535
Phone: (281) 894-8822

The NPI 1003099813 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, iron sucrose, 1 mg (HCPCS:J1756)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Reticulated (young) platelet measurement (HCPCS:85055)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Microscopic examination for white blood cells with manual cell count (HCPCS:85007)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Unclassified drugs (HCPCS:J3490)
  • Drawing of blood for a medical problem (HCPCS:99195)

The enumeration date for this NPI number is 12/14/2007 and was last updated on 4/13/2018.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal Medicine01064564AINDIANANo
2207RH0003XInternal MedicineHematology & OncologyM8807TEXASNo
3207RX0202XInternal MedicineMedical OncologyM8807TEXASYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1281930205MEDICAIDTEXAS
2P01843060OTHERTEXASRAILROAD
3281930206MEDICAIDTEXAS

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.